The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

Item
http://www.wikidata.org/entity/Q36610771
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic miceIn vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer.2-Methoxyestradiol-bis-sulfamate induces apoptosis and autophagy in a tumorigenic breast epithelial cell line.Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines.Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.A molecular understanding of D-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cells2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.17-beta-estradiol analog inhibits cell proliferation by induction of apoptosis in breast cell lines.Sulphamoylated estradiol analogue induces antiproliferative activity and apoptosis in breast cell lines.2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell lineIn vitro effects of an in silico-modelled 17β-estradiol derivative in combination with dichloroacetic acid on MCF-7 and MCF-12A cells.The in vitro effects of a novel estradiol analog on cell proliferation and morphology in human epithelial cervical carcinoma.
P2860

The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.

Item
http://www.wikidata.org/entity/Q36610771
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The therapeutic potential of a ...... t prostate and breast cancers.
@ast
The therapeutic potential of a ...... t prostate and breast cancers.
@en
type
label
The therapeutic potential of a ...... t prostate and breast cancers.
@ast
The therapeutic potential of a ...... t prostate and breast cancers.
@en
prefLabel
The therapeutic potential of a ...... t prostate and breast cancers.
@ast
The therapeutic potential of a ...... t prostate and breast cancers.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
The therapeutic potential of a ...... t prostate and breast cancers.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932